NEW YORK (TheStreet) -- Valeant Pharmaceuticals is upping its bid for Botox maker Allergan by increasing the amount of cash in its offer.
In New York, I'm Brittany Umar for TheStreet.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts